Aprameya Engineering IPO

Aprameya Engineering Limited specialises in the installation, setup, and maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Paediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards. These services are provided on a turnkey basis, including the supply of high-value healthcare and diagnostic equipment to private and government hospitals as well as medical practitioners.

Starting as a partnership firm on September 5, 2003, Aprameya Engineering Limited has evolved to offer comprehensive healthcare solutions. With a deep understanding of medical practitioners’ needs and industry standards, the company provides end-to-end solutions for ICU and operation theatre setups, along with medical equipment that aids in patient treatment, monitoring, and diagnosis.

Since 2020, the company has expanded its business to include turnkey healthcare infrastructure solutions. This includes designing and installing modular and prefabricated operation theatres, ICUs, and other critical care environments. The company’s product portfolio includes high-value medical equipment such as ventilators, patient monitoring systems, critical care equipment, and diagnostic tools.

Aprameya Engineering Limited serves as a dealer for prominent medical equipment manufacturers like Johnson & Johnson Private Limited, Draeger India Private Limited, Philips India Limited, and Siemens Healthcare Private Limited. Over the years, the company has built a wide customer base, including private and government hospitals, medical colleges, and diagnostic service providers across the country. The company has completed numerous projects, including the installation of 1181 critical care beds in Rajasthan, amounting to over ₹12,000 lakh.

The company is led by experienced promoters Saurabh Kishorbhai Bhatt and Chetan Mohan Joshi, who bring over 18 years of expertise in high-value medical equipment. Their knowledge has driven the company’s growth and financial performance, demonstrated by significant revenue increases between Fiscal 2020 and Fiscal 2022. Aprameya Engineering Limited continues to deliver healthcare infrastructure solutions and high-value medical equipment, ensuring cost-effectiveness and improved accessibility for the healthcare sector.

Aprameya Engineering IPO Strengths

• Aprameya Engineering Limited has 20+ years in healthcare, expanding from high-value equipment to turnkey ICU and dialysis setups.
• Aprameya Engineering has successfully installed around 2000 critical care beds and other healthcare facilities across Rajasthan.
• Maintains firm ties with leading medical equipment suppliers like Johnson & Johnson and Siemens for timely and cost-effective procurement.
• The company serves private and government hospitals, medical colleges, and diagnostic centres nationwide, including major institutions in Rajasthan.
• Promoters with 20 years in the industry and a skilled management team drive Aprameya’s growth and market expansion.
• The company operates efficiently without heavy fixed asset investments, focusing on capital efficiency, low debt, and consistent revenue growth.

Aprameya Engineering IPO Risks

• Aprameya Engineering Limited can have a substantial financial impact from losing key customers or facing reduced demand from major clients.
• Aprameya Engineering Limited may face adverse effects due to uncertainties and unfavourable terms in competitive bidding for government contracts.
• A decline in healthcare spending could severely impact Aprameya Engineering Limited’s revenues and cash flow.
• The Order Book of Aprameya Engineering Limited may not accurately reflect future earnings, risking unexpected income shortfalls.
• Aprameya Engineering Limited’s recent diversification into new business areas poses risks due to limited experience and potential unforeseen challenges.
• Risks from third-party suppliers could disrupt Aprameya Engineering Limited’s operations if medical equipment procurement is delayed or costs increase.